The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.

Lung cancer is among the most lethal malignancies with a high metastasis and recurrence rate, which is probably due to the existence of lung cancer stem cells (CSCs). CSCs in many tumors including non-small cell lung cancer (NSCLC) have been identified using adhesion molecular CD44, either individua...

Full description

Bibliographic Details
Main Authors: Yang Shi, Can Liu, Xin Liu, Dean G Tang, Junchen Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3942411?pdf=render
_version_ 1818300259593355264
author Yang Shi
Can Liu
Xin Liu
Dean G Tang
Junchen Wang
author_facet Yang Shi
Can Liu
Xin Liu
Dean G Tang
Junchen Wang
author_sort Yang Shi
collection DOAJ
description Lung cancer is among the most lethal malignancies with a high metastasis and recurrence rate, which is probably due to the existence of lung cancer stem cells (CSCs). CSCs in many tumors including non-small cell lung cancer (NSCLC) have been identified using adhesion molecular CD44, either individually or in combination with other marker(s). MicroRNAs (miRNAs) regulate both normal stem cells and CSCs and dysregulation of miRNAs has been implicated in tumorigenesis. Recently, miR-34a was found to be downregulated in NSCLC cells but the biological functions of miR-34a in regulating NSCLC cell behavior have not been extensively studied. Here we show that transfection of synthetic miR-34a, but not the negative control (NC) miRNA oligonucleotides (oligos) in three NSCLC cell lines, i.e., A549, H460, and H1299, inhibited their holoclone formation, clonogenic expansion, and tumor regeneration in vivo. Furthermore, the lentiviral vector-mediated overexpression of miR-34a in purified CD44hi H460 cells also inhibited tumor outgrowth. In contrast, expression of miR-34a antagomirs (i.e., antisense oligos) in the CD44lo H460 cells promoted tumor development. Our study shows that miR-34a is a negative regulator of the tumorigenic properties of NSCLC cells and CD44hi lung CSCs, and establishes a strong rationale for developing miR-34a as a novel therapeutic agent against NSCLC.
first_indexed 2024-12-13T05:04:17Z
format Article
id doaj.art-dfcb46033b9a476ca19adf3a13da67be
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T05:04:17Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-dfcb46033b9a476ca19adf3a13da67be2022-12-21T23:58:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9002210.1371/journal.pone.0090022The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.Yang ShiCan LiuXin LiuDean G TangJunchen WangLung cancer is among the most lethal malignancies with a high metastasis and recurrence rate, which is probably due to the existence of lung cancer stem cells (CSCs). CSCs in many tumors including non-small cell lung cancer (NSCLC) have been identified using adhesion molecular CD44, either individually or in combination with other marker(s). MicroRNAs (miRNAs) regulate both normal stem cells and CSCs and dysregulation of miRNAs has been implicated in tumorigenesis. Recently, miR-34a was found to be downregulated in NSCLC cells but the biological functions of miR-34a in regulating NSCLC cell behavior have not been extensively studied. Here we show that transfection of synthetic miR-34a, but not the negative control (NC) miRNA oligonucleotides (oligos) in three NSCLC cell lines, i.e., A549, H460, and H1299, inhibited their holoclone formation, clonogenic expansion, and tumor regeneration in vivo. Furthermore, the lentiviral vector-mediated overexpression of miR-34a in purified CD44hi H460 cells also inhibited tumor outgrowth. In contrast, expression of miR-34a antagomirs (i.e., antisense oligos) in the CD44lo H460 cells promoted tumor development. Our study shows that miR-34a is a negative regulator of the tumorigenic properties of NSCLC cells and CD44hi lung CSCs, and establishes a strong rationale for developing miR-34a as a novel therapeutic agent against NSCLC.http://europepmc.org/articles/PMC3942411?pdf=render
spellingShingle Yang Shi
Can Liu
Xin Liu
Dean G Tang
Junchen Wang
The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
PLoS ONE
title The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
title_full The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
title_fullStr The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
title_full_unstemmed The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
title_short The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
title_sort microrna mir 34a inhibits non small cell lung cancer nsclc growth and the cd44hi stem like nsclc cells
url http://europepmc.org/articles/PMC3942411?pdf=render
work_keys_str_mv AT yangshi themicrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT canliu themicrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT xinliu themicrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT deangtang themicrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT junchenwang themicrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT yangshi micrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT canliu micrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT xinliu micrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT deangtang micrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells
AT junchenwang micrornamir34ainhibitsnonsmallcelllungcancernsclcgrowthandthecd44histemlikensclccells